BrightSpring Q2 Revenue Jumps 23%, Net Income Soars to $87M; Full-Year Guidance Raised
BTSG has more than doubled off its 52-week low of $19.01.
Summary
BrightSpring Health Services reported Q2 2026 results that crushed year-ago figures — revenue up 23%, net income of $87M vs $9M — and raised full-year guidance across the board. The quarter also featured a $300M debt paydown and lower leverage.
Key Events · Earnings and Guidance · BTSG
-
Q2 Revenue +23%, Net Income $87M
Revenue reached $3,873 million, up 23.0% year-over-year, driven by 22% growth in Pharmacy Solutions and 30% growth in Provider Services. Net income from continuing operations was $86.6 million, compared to just $8.5 million a year ago.
-
Adjusted EBITDA Surges 44%
Adjusted EBITDA hit $206 million, a 44.2% increase from $143 million in Q2 2025, with segment EBITDA up 41% and corporate costs well controlled.
-
Full-Year Guidance Raised
Management lifted 2026 revenue guidance to $15.1–$15.425 billion (17–19.5% growth) and Adjusted EBITDA to $820–$845 million (32.8–36.8% growth), reflecting strong momentum and the Amedisys/LHC branches acquisition contribution.
-
Balance Sheet Strengthened
Leverage improved to 2.15x from 2.27x at March 31, 2026, following a $300 million paydown and modification of the First Lien Facility that also reduced interest costs.
Analysis · BTSG · Industrial Applications And Services
BrightSpring delivered a standout quarter, with revenue up 23% and net income surging nearly tenfold to $87 million. Adjusted EBITDA grew 44%, and the company raised its full-year revenue and profit outlook well above prior expectations. The balance sheet also strengthened — leverage fell to 2.15x after a $300 million debt paydown and interest-rate refinancing. This is a clear beat-and-raise quarter that confirms the business is firing on all cylinders following the Community Living divestiture.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BTSG was trading at $73.20 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $14.3B. The 52-week trading range was $19.01 to $73.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.